Cargando…
CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208876/ https://www.ncbi.nlm.nih.gov/pubmed/35747591 http://dx.doi.org/10.1097/HS9.0000000000000733 |
| _version_ | 1784729807452372992 |
|---|---|
| author | Rösler, Wiebke Bink, Andrea Bissig, Marina Imbach, Lukas Marques Maggio, Ewerton Manz, Markus G. Müller, Thomas Roth, Patrick Rushing, Elisabeth Widmer, Corinne Zenz, Thorsten von Moos, Seraina Müller, Antonia M. S. |
| author_facet | Rösler, Wiebke Bink, Andrea Bissig, Marina Imbach, Lukas Marques Maggio, Ewerton Manz, Markus G. Müller, Thomas Roth, Patrick Rushing, Elisabeth Widmer, Corinne Zenz, Thorsten von Moos, Seraina Müller, Antonia M. S. |
| author_sort | Rösler, Wiebke |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9208876 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92088762022-06-22 CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS Rösler, Wiebke Bink, Andrea Bissig, Marina Imbach, Lukas Marques Maggio, Ewerton Manz, Markus G. Müller, Thomas Roth, Patrick Rushing, Elisabeth Widmer, Corinne Zenz, Thorsten von Moos, Seraina Müller, Antonia M. S. Hemasphere Case Report Lippincott Williams & Wilkins 2022-06-17 /pmc/articles/PMC9208876/ /pubmed/35747591 http://dx.doi.org/10.1097/HS9.0000000000000733 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Case Report Rösler, Wiebke Bink, Andrea Bissig, Marina Imbach, Lukas Marques Maggio, Ewerton Manz, Markus G. Müller, Thomas Roth, Patrick Rushing, Elisabeth Widmer, Corinne Zenz, Thorsten von Moos, Seraina Müller, Antonia M. S. CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS |
| title | CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS |
| title_full | CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS |
| title_fullStr | CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS |
| title_full_unstemmed | CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS |
| title_short | CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS |
| title_sort | car t-cell infusion following checkpoint inhibition can induce remission in chemorefractory post-transplant lymphoproliferative disorder of the cns |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208876/ https://www.ncbi.nlm.nih.gov/pubmed/35747591 http://dx.doi.org/10.1097/HS9.0000000000000733 |
| work_keys_str_mv | AT roslerwiebke cartcellinfusionfollowingcheckpointinhibitioncaninduceremissioninchemorefractoryposttransplantlymphoproliferativedisorderofthecns AT binkandrea cartcellinfusionfollowingcheckpointinhibitioncaninduceremissioninchemorefractoryposttransplantlymphoproliferativedisorderofthecns AT bissigmarina cartcellinfusionfollowingcheckpointinhibitioncaninduceremissioninchemorefractoryposttransplantlymphoproliferativedisorderofthecns AT imbachlukas cartcellinfusionfollowingcheckpointinhibitioncaninduceremissioninchemorefractoryposttransplantlymphoproliferativedisorderofthecns AT marquesmaggioewerton cartcellinfusionfollowingcheckpointinhibitioncaninduceremissioninchemorefractoryposttransplantlymphoproliferativedisorderofthecns AT manzmarkusg cartcellinfusionfollowingcheckpointinhibitioncaninduceremissioninchemorefractoryposttransplantlymphoproliferativedisorderofthecns AT mullerthomas cartcellinfusionfollowingcheckpointinhibitioncaninduceremissioninchemorefractoryposttransplantlymphoproliferativedisorderofthecns AT rothpatrick cartcellinfusionfollowingcheckpointinhibitioncaninduceremissioninchemorefractoryposttransplantlymphoproliferativedisorderofthecns AT rushingelisabeth cartcellinfusionfollowingcheckpointinhibitioncaninduceremissioninchemorefractoryposttransplantlymphoproliferativedisorderofthecns AT widmercorinne cartcellinfusionfollowingcheckpointinhibitioncaninduceremissioninchemorefractoryposttransplantlymphoproliferativedisorderofthecns AT zenzthorsten cartcellinfusionfollowingcheckpointinhibitioncaninduceremissioninchemorefractoryposttransplantlymphoproliferativedisorderofthecns AT vonmoosseraina cartcellinfusionfollowingcheckpointinhibitioncaninduceremissioninchemorefractoryposttransplantlymphoproliferativedisorderofthecns AT mullerantoniams cartcellinfusionfollowingcheckpointinhibitioncaninduceremissioninchemorefractoryposttransplantlymphoproliferativedisorderofthecns |